NEU 2.03% $13.53 neuren pharmaceuticals limited

Just a couple of bald facts in relation to the upcoming Acadia...

  1. 2,869 Posts.
    lightbulb Created with Sketch. 575
    Just a couple of bald facts in relation to the upcoming Acadia earnings call:
    *1-year ago [Q2 2023] Acadia reported a quarterly revenue of $165.2M with Daybue accounting for just 14.0% of that total.
    *The difference between 18 analyst average revenue estimates for the quarter 1-year later[$235.4M for Q2 2024] is $70.2M.This requires an increase in revenue of 42.4%[say about $18M per quarter] for the the full year to meet consensus estimates..
    *In Q1 2024 Daybue revenue alone was $75.9M [in a quarter with seasonal issues].These numbers suggest that if the wheels have not entirely come off either of Acadias two revenue streams then the achievement of the indicated revenue price targets is entirely feasable.
    *My understanding is that there is no Q2 2024 revenue guidance for Daybue revenue.
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.53
Change
-0.280(2.03%)
Mkt cap ! $1.726B
Open High Low Value Volume
$13.82 $13.91 $13.51 $2.326M 170.2K

Buyers (Bids)

No. Vol. Price($)
16 472 $13.52
 

Sellers (Offers)

Price($) Vol. No.
$13.53 86 2
View Market Depth
Last trade - 14.00pm 11/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.